The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Multicenter feasibility study of chemoradiation, trastuzumab and pertuzumab in resectable HER2+ esophageal carcinoma: the TRAP study.
 
Stephanie van der Woude
No Relationships to Disclose
 
Sybren L. Meijer
No Relationships to Disclose
 
Maarten Hulshof
No Relationships to Disclose
 
Suzanne S Gisbertz
No Relationships to Disclose
 
Sheila Krishnadath
No Relationships to Disclose
 
Cornelis J. A. Punt
Consulting or Advisory Role - Amgen; Bayer; Merck Serono; Roche
 
Marc J. van de Vijver
No Relationships to Disclose
 
Fabienne Warmerdam
No Relationships to Disclose
 
Geert-Yan Creemers
No Relationships to Disclose
 
Marije Slingerland
No Relationships to Disclose
 
Maartje Los
No Relationships to Disclose
 
Geke Hospers
No Relationships to Disclose
 
Laurens Victor Beerepoot
No Relationships to Disclose
 
Nadia Haj Mohammad
No Relationships to Disclose
 
Jolanda van Dieren
No Relationships to Disclose
 
Mark I. van Berge Henegouwen
No Relationships to Disclose
 
Hanneke W.M. Van Laarhoven
Consulting or Advisory Role - Lilly; Nordic Group
Research Funding - Bayer (Inst); Celgene (Inst); Janssen-Cilag (Inst); Lilly (Inst); Nordic Group (Inst); Roche (Inst)